These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 9066172
1. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I. al Gohary OM. Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172 [Abstract] [Full Text] [Related]
2. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids. Lin MS, Sun P, Yu HY. J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281 [Abstract] [Full Text] [Related]
3. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide. Hem SL, White JL, Buehler JD, Luber JR, Grim WM, Lipka EA. Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862 [Abstract] [Full Text] [Related]
4. Magaldrate stimulates endogenous prostaglandin E2 synthesis in human gastric mucosa in vitro and in vivo. Schmidt C, Baumeister B, Kipnowski J, Miederer SE, Vetter H. Hepatogastroenterology; 1998 Nov; 45(24):2443-6. PubMed ID: 9951941 [Abstract] [Full Text] [Related]
7. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids. Beneyto JE, Fábregas JL. Arzneimittelforschung; 1984 Nov; 34(10A):1357-60. PubMed ID: 6391496 [Abstract] [Full Text] [Related]
8. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat. Borella LE, DiJoseph JF, Mir GN. Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181 [Abstract] [Full Text] [Related]
10. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)]. Baur C, Becker A, Linder R, Schwan T. Arzneimittelforschung; 1981 Jul; 31(3):504-7. PubMed ID: 6784737 [Abstract] [Full Text] [Related]
11. Evaluation of a new antacid, almagate. Beneyto JE, Fábregas JL, Moragues J, Spickett RG. Arzneimittelforschung; 1984 Jul; 34(10A):1350-4. PubMed ID: 6439224 [Abstract] [Full Text] [Related]
15. Effect of antacid magaldrate oral suspension on in-vitro and in-vivo availability of indomethacin in dogs. al-Gohary OM, Hosny EA. Pharm Acta Helv; 1997 Apr; 72(2):81-6. PubMed ID: 9112830 [Abstract] [Full Text] [Related]
16. [Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl)]. Dammann HG, Flashoff D, Müller P, Kather H, Simon B. Dtsch Med Wochenschr; 1981 Oct 30; 106(44):1457-8. PubMed ID: 7297433 [Abstract] [Full Text] [Related]
18. Evaluation of antacid tablets and liquid in fasting and fed men and women. Thomson AB, Pinchbeck B, Kirdeikis J, Kirdeikis P, Zuk L, Brunet MK, Jurima-Romet M, Murray PE. Clin Ther; 1988 Oct 30; 10(2):158-68. PubMed ID: 3273863 [Abstract] [Full Text] [Related]
19. Acid-neutralizing capacity and sodium content of antacid products from Belgium. Gombatz VW. Clin Ther; 1984 Oct 30; 6(2):151-4. PubMed ID: 6705010 [Abstract] [Full Text] [Related]
20. Comparison of the antacid properties of almagate and aluminium hydroxide against pentagastrin-induced gastric secretion in healthy volunteers. Balanzó J, Guarner C, Vilardell F. Arzneimittelforschung; 1984 Oct 30; 34(10A):1375-7. PubMed ID: 6439225 [Abstract] [Full Text] [Related] Page: [Next] [New Search]